http://www.nabp.net/cpes09.asp
2009 Symposium
Continuing Pharmacy Education Sessions
The following presentations were given at the NABP 2009 Symposium.
Legalization of Drugs: Is the Time Right for Medical Marijuana?
Issue Introduction and Overview
A speaker will provide Symposium participants with facts about the medical use of marijuana, emphasizing evidence-based medicine, including the scientific evidence bearing on potential medical use. This introduction opens the door for further discussion regarding science, medicine, policy, and the law.
Kenneth Mackie, MD, Linda and Jack Gill Chair of Neuroscience and Professor, Department of Psychological and Brain Sciences, Indiana University Bloomington
The Scientific Side of Medical Marijuana
Should Marijuana be a Medical Option?
Participants will learn about the marijuana policies of some of the major health care associations and the largest national member-based organization of patients, medical professionals, scientists, and concerned citizens promoting safe and legal access to cannabis for therapeutic use and research. Do they all support medical marijuana? Do they all recommend additional trials and rescheduling?
Barry D. Dickinson, PhD, Director, Science & Biotechnology, and Secretary, Council on Science and Public Health, American Medical Association
Should Marijuana be a Medical Option?
Alice Mead, JD, Director of United States Professional Relations, GW Pharmaceuticals
Should Marijuana be a Medical Option?
Are These Medical Miracles?
Highly esteemed physicians will provide real-life examples of successful medical marijuana treatment and why legal prescription medications are not always the answer in providing the best patient care.
Sunil K. Aggarwal, PhD, MS-IV, Medical Student/Researcher, University of Washington School of Medicine
Gregory T. Carter, MD, MS, Professor of Rehabilitation Medicine, University of Washington School of Medicine
Cannabis in the Treatment of Chronic Pain
Donald I. Abrams, MD, Professor of Clinical Medicine, University of California, San Francisco
Cannabis in the Treatment of Chronic Pain
Are We Going to Legalize Medical Marijuana?
A Regulatory Approach to Medical Marijuana – What are the States Doing?
Representatives from state agencies will share with participants how medical marijuana programs have been incorporated into their state’s laws and regulations. How were they developed? How were they implemented? How are they enforced? Do they work?
Jacob Appelsmith, JD, Special Assistant to the Attorney General, California Office of the Attorney General
California and Medical Marijuana
Lloyd K. Jessen, RPh, JD, Executive Director and Drug Control Program Administrator, Iowa Board of Pharmacy
Déjà vu: Medical Marijuana in Iowa 1979 to 2009
Scott Galenbeck, JD, Assistant Attorney General, Iowa Office of the Attorney General
Ditch-Weed Saga
A Regulatory Approach to Medical Marijuana – What has Canada Done?
Symposium participants will learn about the development of the Marihuana Medical Access Regulations in Canada and their implementation. In addition, operational aspects, including marijuana supply; policies; and legal issues will be addressed.
Carole Bouchard, BPharm, MAP, Executive Director, National Association of Pharmacy Regulatory Authorities
A Regulatory Approach to Medical Marihuana – What has Canada Done?
Legalizing Medical Marijuana – Creating a Slippery Slope?
What impact could legalizing medical marijuana bring? Will it lead us down a path to legalize other “immoral” behaviors? Will it increase recreational marijuana and other illicit drug use? Experts will provide participants with their insights including whether legalizing medical marijuana could help our ailing economy by becoming a source of tax revenue and decreasing money spent on criminal prosecutions.
Andrea Barthwell, MD, FASAM, Founder and Chief Executive Officer, EMGlobal LLC, and Former Deputy Director for Demand Reduction, Office of National Drug Control Policy
Legalizing “Medical Marijuana” – Creating a Slippery Slope?